Colgate-Palmolive Company [CL] Revenue clocked in at $17.48 billion, down -7.21% YTD: What’s Next?


Colgate-Palmolive Company [NYSE: CL] price surged by 0.55 percent to reach at $0.43. The company report on July 15, 2022 that Colgate-Palmolive Webcasts 2022 Second Quarter Earnings Conference Call July 29, 2022 – 8:00 a.m. ET.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2022 second quarter earnings conference call on Friday, July 29, 2022, at 8:00 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and SVP, M&A, John Faucher. At approximately 7:00 a.m. ET, the Company will post its prepared materials (in PDF format) regarding its 2022 second quarter results to the Investor Center section of its website at

Investors may access the live audio webcast on Colgate’s website at For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate’s website.

A sum of 5070849 shares traded at recent session while its average daily volume was at 4.77M shares. Colgate-Palmolive Company shares reached a high of $79.70 and dropped to a low of $78.51 until finishing in the latest session at $79.19.

The one-year CL stock forecast points to a potential upside of 2.29. The average equity rating for CL stock is currently 2.80, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Colgate-Palmolive Company [CL]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CL shares is $81.05 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CL stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Atlantic Equities have made an estimate for Colgate-Palmolive Company shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 03, 2022. While these analysts kept the previous recommendation, Raymond James raised their target price to Mkt Perform. The new note on the price target was released on April 08, 2022, representing the official price target for Colgate-Palmolive Company stock. Previously, the target price had yet another raise to $83, while Bernstein analysts kept a Mkt Perform rating on CL stock. On January 31, 2022, analysts decreased their price target for CL shares from 78 to 76.

The Average True Range (ATR) for Colgate-Palmolive Company is set at 1.39, with the Price to Sales ratio for CL stock in the period of the last 12 months amounting to 3.73. The Price to Book ratio for the last quarter was 208.39, with the Price to Cash per share for the same quarter was set at 1.14. Price to Free Cash Flow for CL in the course of the last twelve months was 76.75 with Quick ratio for the last quarter at 0.70.

CL Stock Performance Analysis:

Colgate-Palmolive Company [CL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.98. With this latest performance, CL shares gained by 0.39% in over the last four-week period, additionally sinking by -2.70% over the last 6 months – not to mention a drop of -4.80% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CL stock in for the last two-week period is set at 55.64, with the RSI for the last a single of trading hit 59.68, and the three-weeks RSI is set at 53.82 for Colgate-Palmolive Company [CL]. The present Moving Average for the last 50 days of trading for this stock 77.89, while it was recorded at 78.36 for the last single week of trading, and 78.61 for the last 200 days.

Insight into Colgate-Palmolive Company Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Colgate-Palmolive Company [CL] shares currently have an operating margin of +22.31 and a Gross Margin at +59.08. Colgate-Palmolive Company’s Net Margin is presently recorded at +12.43.

Return on Equity for this stock inclined to 320.41, with Return on Assets sitting at 13.99.

Colgate-Palmolive Company’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 1.10.

CL Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Colgate-Palmolive Company go to 3.82%.

Colgate-Palmolive Company [CL] Insider Position Details

There are presently around $52,290 million, or 81.40% of CL stock, in the hands of institutional investors. The top three institutional holders of CL stocks are: VANGUARD GROUP INC with ownership of 77,195,703, which is approximately 0.585% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 66,575,004 shares of the stock with an approximate value of $5.27 billion in CL stocks shares; and STATE STREET CORP, currently with $3.93 billion in CL stock with ownership of nearly 0.648% of the company’s market capitalization.

Positions in Colgate-Palmolive Company stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 679 institutional holders increased their position in Colgate-Palmolive Company [NYSE:CL] by around 37,157,223 shares. Additionally, 735 investors decreased positions by around 37,610,965 shares, while 360 investors held positions by with 585,540,995 shares. The mentioned changes placed institutional holdings at 660,309,183 shares, according to the latest SEC report filing. CL stock had 112 new institutional investments in for a total of 3,728,645 shares, while 125 institutional investors sold positions of 1,843,502 shares during the same period.